ES2167581T3 - Composiciones y procedimientos para estabilizar polimeros. - Google Patents

Composiciones y procedimientos para estabilizar polimeros.

Info

Publication number
ES2167581T3
ES2167581T3 ES96922797T ES96922797T ES2167581T3 ES 2167581 T3 ES2167581 T3 ES 2167581T3 ES 96922797 T ES96922797 T ES 96922797T ES 96922797 T ES96922797 T ES 96922797T ES 2167581 T3 ES2167581 T3 ES 2167581T3
Authority
ES
Spain
Prior art keywords
formulations
procedures
compositions
stabilizing polymers
phenphosphonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96922797T
Other languages
English (en)
Spanish (es)
Inventor
Fu-Pao Tsao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2167581T3 publication Critical patent/ES2167581T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/49—Phosphorus-containing compounds
    • C08K5/51—Phosphorus bound to oxygen
    • C08K5/53—Phosphorus bound to oxygen bound to oxygen and to carbon only
    • C08K5/5317—Phosphonic compounds, e.g. R—P(:O)(OR')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
ES96922797T 1995-06-22 1996-06-12 Composiciones y procedimientos para estabilizar polimeros. Expired - Lifetime ES2167581T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/493,761 US5683993A (en) 1995-06-22 1995-06-22 Compositions and methods for stabilizing polymers

Publications (1)

Publication Number Publication Date
ES2167581T3 true ES2167581T3 (es) 2002-05-16

Family

ID=23961593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96922797T Expired - Lifetime ES2167581T3 (es) 1995-06-22 1996-06-12 Composiciones y procedimientos para estabilizar polimeros.

Country Status (13)

Country Link
US (2) US5683993A (2)
EP (1) EP0833609B1 (2)
JP (3) JP4260881B2 (2)
AT (1) ATE208189T1 (2)
AU (1) AU715686B2 (2)
CA (1) CA2222646C (2)
CY (1) CY2323B1 (2)
DE (1) DE69616791T2 (2)
DK (1) DK0833609T3 (2)
ES (1) ES2167581T3 (2)
PT (1) PT833609E (2)
TW (1) TW358109B (2)
WO (1) WO1997000669A1 (2)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0995435B1 (en) * 1997-05-14 2007-04-25 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
EP0893121B1 (en) * 1997-06-27 2002-03-13 Akzo Nobel N.V. Oral liquid medicine solution
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US6627660B1 (en) * 1999-11-16 2003-09-30 New River Pharmaceuticals Inc. Stabilized thyroxine compounds
DE60144305D1 (de) 2000-11-17 2011-05-05 Kyowa Hakko Kirin Co Ltd Expression von xenogenen (humanen) Immunglobulinen in klonierten, transgenen Huftieren
JP4436131B2 (ja) * 2001-11-21 2010-03-24 イオルテク ヒアルロン酸を安定化させる組成物
US20040115160A1 (en) * 2002-12-13 2004-06-17 Salamone Joseph C. Quaternary ammonium esters for disinfection and preservation
US20050084468A1 (en) * 2003-10-17 2005-04-21 Colgate-Palmolive Company Antimicrobial cleaning composition
KR101454674B1 (ko) 2006-03-17 2014-10-27 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물
JP5160757B2 (ja) * 2006-09-01 2013-03-13 ホーユー株式会社 毛髪脱染剤組成物
WO2008036855A2 (en) * 2006-09-21 2008-03-27 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
KR101421519B1 (ko) * 2006-09-28 2014-07-30 알콘 리서치, 리미티드 자기 보존 수성 약제학적 조성물
RU2445950C2 (ru) * 2006-10-26 2012-03-27 Сэндзю Фармасьютикал Ко., Лтд. Жидкая водная глазная композиция
DK2141985T3 (en) 2007-03-28 2019-02-04 Univ Iowa Res Found Transgenetic pig model of cystic fibrosis
US8759321B2 (en) 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
US8119112B2 (en) 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
ES2638771T3 (es) * 2008-03-17 2017-10-24 Novartis Ag Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
TWI489997B (zh) * 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
KR102807016B1 (ko) 2011-05-16 2025-05-14 더 큐레이터스 오브 더 유니버시티 오브 미주리 돼지 생식기 호흡기 증후군 바이러스 내성 동물
CA2853292C (en) 2011-11-03 2021-12-14 University Of Iowa Research Foundation Transgenic pig models of cystic fibrosis
US20130177599A1 (en) * 2012-01-06 2013-07-11 Insite Vision Incorporated Methods and kits for extending contact lens use
KR101400791B1 (ko) 2012-10-04 2014-05-29 주식회사대성미생물연구소 동물용 복합 기능성 항생제 조성물
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
US10231961B1 (en) 2017-02-07 2019-03-19 Genus Lifesciences Inc. Pharmaceutical compositions and methods of using the same
US10149843B1 (en) 2017-02-07 2018-12-11 Gneus Lifescineces Inc. Pharmaceutical compositions and methods of using the same
US10413505B1 (en) 2017-02-07 2019-09-17 Genus Lifesciences Inc. Pharmaceutical compositions and methods of using the same
CN109387622A (zh) * 2018-03-02 2019-02-26 国家纳米科学中心 一种高分子材料表面修饰方法及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322883A1 (de) * 1973-05-07 1974-11-28 Roehm Gmbh Wasserloesliche polymerisate
DE2743764C2 (de) * 1977-09-29 1982-07-22 Hoechst Ag, 6000 Frankfurt Wäßrige Kunststoffdispersion auf Basis von Vinylpolymeren
DE2810348A1 (de) * 1978-03-10 1979-09-20 Hoechst Ag Waessrige kunststoffdispersion auf basis von vinylpolymeren
US4303568A (en) * 1979-12-10 1981-12-01 Betz Laboratories, Inc. Corrosion inhibition treatments and method
US4474916A (en) * 1982-07-27 1984-10-02 Basf Aktiengesellschaft Concentrated aqueous solutions of mixtures of organic complexing agents and dispersing agents based on polymeric aliphatic carboxylic acids
AU565354B2 (en) * 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
US4540738A (en) * 1984-12-07 1985-09-10 The Kendall Company Acrylic adhesive composition comprising an alpha amino phosphonic acid or salt having improved stability
US4889689A (en) * 1986-10-14 1989-12-26 Ciba-Geigy Corporation Method of disinfecting a soft contact lens with a diethylene triamine penta(methylenephosphonic acid) stabilized hydrogen peroxide solution
US4900469A (en) * 1986-10-21 1990-02-13 The Clorox Company Thickened peracid precursor compositions
US4812173A (en) * 1987-05-01 1989-03-14 Ciba-Geigy Corporation Stabilized hydrogen peroxide contact lens disinfecting solution
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
DE3805663A1 (de) * 1988-02-24 1989-09-07 Henkel Kgaa Oxaalkanpolyphosphonsaeuren, ihre verwendung als thresholder sowie diese verbindungen enthaltende, komplexierend wirkende zusammensetzungen
IL91131A (en) * 1988-08-04 1993-06-10 Ciba Geigy Ag Method of preserving ophthalmic solutions using a hydrogen peroxide source and compositions therefor
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5034556A (en) * 1989-04-03 1991-07-23 Ppg Industries, Inc. Reaction products of alpha-aminomethylene phosphonic acids and epoxy compounds and their use in coating compositions
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
DE69107056T4 (de) * 1990-11-14 1996-06-13 L'oreal, Paris Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
EP0766970A3 (en) * 1990-12-27 2000-02-23 Allergan, Inc Method and composition for disinfecting contact lenses
JP3107873B2 (ja) * 1991-09-26 2000-11-13 ユニ・チャーム株式会社 高吸水性ポリマーの経時着色防止方法および経時着色防止剤
EP0544377B1 (en) * 1991-11-26 1996-05-22 ENIRICERCHE S.p.A. Aqueous gellable composition containing an anti-syneresis agent
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
SE500660C2 (sv) * 1992-12-03 1994-08-01 Mo Och Domsjoe Ab Förfarande för framställning av grönlut vid kemikalieåtervinning i sulfat- och sulfitmassafabriker
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
DE59407521D1 (de) * 1993-08-10 1999-02-04 Ciba Geigy Ag Mercerisiernetzmittel
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds

Also Published As

Publication number Publication date
TW358109B (en) 1999-05-11
CA2222646C (en) 2009-12-08
AU715686B2 (en) 2000-02-10
US5683993A (en) 1997-11-04
JP4260881B2 (ja) 2009-04-30
JP2008248246A (ja) 2008-10-16
JP2012153710A (ja) 2012-08-16
EP0833609B1 (en) 2001-11-07
PT833609E (pt) 2002-04-29
DE69616791D1 (de) 2001-12-13
JPH11510480A (ja) 1999-09-14
EP0833609A1 (en) 1998-04-08
ATE208189T1 (de) 2001-11-15
DK0833609T3 (da) 2002-02-18
DE69616791T2 (de) 2002-05-29
CY2323B1 (en) 2003-11-14
CA2222646A1 (en) 1997-01-09
US5858996A (en) 1999-01-12
AU6355196A (en) 1997-01-22
WO1997000669A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
ES2167581T3 (es) Composiciones y procedimientos para estabilizar polimeros.
WO2004043432A3 (en) Controlled release depot formulations
AU592123B2 (en) Color stabilized hydrogel dressing and process
AR111679A2 (es) Formulación farmacéutica de liberación controlada, procesos, usos, método
ATE203157T1 (de) Injizierbare depotgelzubereitung und herstellungsverfahren
EP2266607A3 (en) Immunoconjugates for treating cancer
NZ541593A (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
EP0462608B1 (de) Implantierbares Wirkstoffdepotmaterial
AU2001295017A1 (en) Solid dose nanoparticulate compositions
PE20050494A1 (es) Excipientes en vehiculos de suministro de farmacos
MX9703429A (es) Composiciones hermorroidales y metodos de uso.
EP0804595A4 (2)
AU7983901A (en) Biologically active material
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
IL142470A0 (en) Controlled release liquid delivery compositions with low initial drug burst
KR102131272B1 (ko) 치아용 패치의 부착성이 향상된 겔 조성물
ES2159783T3 (es) Composicion oftalmologica con tiempo prolongado de residencia en el ojo.
AU6769701A (en) Sprayable wound care compositions
PE44799A1 (es) Antagonistas del receptor de vitronectina
CA2251281A1 (en) Drug composition with controlled drug release rate
KR102241995B1 (ko) 치아용 패치의 부착성이 향상된 겔 조성물
CA2529441A1 (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
MX172630B (es) Composisiones mejoradas de polimeros que contienen fosforo que comprenden compuestos de metales polivalentes solubles en agua
MX2025001571A (es) Matrices bioactivas impresas en tres dimensiones (3d)
AU2360592A (en) Polyacrylic acid based ophthalmic compositions